These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15139041)

  • 21. mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer.
    Tian L; Chen C; Guo Y; Zhang F; Mi J; Feng Q; Lin S; Xi N; Tian J; Yu L; Chen Y; Cao M; Lai C; Fan J; Zhang Y; Chen G
    Neoplasia; 2021 Jul; 23(7):643-652. PubMed ID: 34126361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors.
    Rawson JM; Heineman RH; Beach LB; Martin JL; Schnettler EK; Dapp MJ; Patterson SE; Mansky LM
    Bioorg Med Chem; 2013 Nov; 21(22):7222-8. PubMed ID: 24120088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd).
    Zahedi Avval F; Berndt C; Pramanik A; Holmgren A
    Biochem Biophys Res Commun; 2009 Feb; 379(3):775-9. PubMed ID: 19121624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotide reductase M2 subunit.
    Jung CP; Motwani MV; Schwartz GK
    Clin Cancer Res; 2001 Aug; 7(8):2527-36. PubMed ID: 11489836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribonucleotide reductase inhibition improves the symptoms of a Caenorhabditis elegans model of Alzheimer's disease.
    Brokate-Llanos AM; Sanchez-Ibañez M; Pérez-Jiménez MM; Monje-Moreno JM; Gómez-Marín C; Caro C; Vivar-Rios C; Moreno-Mateos MA; García-Martín ML; Muñoz MJ; Royo JL
    G3 (Bethesda); 2024 May; 14(5):. PubMed ID: 38412549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): a combined experimental and theoretical study.
    Popović-Bijelić A; Kowol CR; Lind ME; Luo J; Himo F; Enyedy EA; Arion VB; Gräslund A
    J Inorg Biochem; 2011 Nov; 105(11):1422-31. PubMed ID: 21955844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and virtual screening towards synthesis of novel substituted thiosemicarbozones as ribonuleotide reductase (RNR) inhibitors with improved cellular trafficking and anticancer activity.
    Gokhale N; Jain S; Yadav M
    Curr Top Med Chem; 2015; 15(1):37-42. PubMed ID: 25579572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of ribonucleotide reductase inhibitors: a review on structure activity relationships.
    Moorthy NS; Cerqueira NM; Ramos MJ; Fernandes PA
    Mini Rev Med Chem; 2013 Nov; 13(13):1862-72. PubMed ID: 24032510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A ribonucleotide reductase inhibitor with deoxyribonucleoside-reversible cytotoxicity.
    Crona M; Codó P; Jonna VR; Hofer A; Fernandes AP; Tholander F
    Mol Oncol; 2016 Nov; 10(9):1375-1386. PubMed ID: 27511871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2'-Deoxy-2'-methylenecytidine and 2'-deoxy-2',2'-difluorocytidine 5'-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase.
    Baker CH; Banzon J; Bollinger JM; Stubbe J; Samano V; Robins MJ; Lippert B; Jarvi E; Resvick R
    J Med Chem; 1991 Jun; 34(6):1879-84. PubMed ID: 2061926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of DNA synthesis inhibition in the cytotoxicity of 2',2'-difluoro-2'-deoxycytidine.
    Ostruszka LJ; Shewach DS
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):325-32. PubMed ID: 12811514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase.
    Rawson JMO; Roth ME; Xie J; Daly MB; Clouser CL; Landman SR; Reilly CS; Bonnac L; Kim B; Patterson SE; Mansky LM
    Bioorg Med Chem; 2016 Jun; 24(11):2410-2422. PubMed ID: 27117260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
    Lin ZP; Belcourt MF; Cory JG; Sartorelli AC
    J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors.
    Minami K; Shinsato Y; Yamamoto M; Takahashi H; Zhang S; Nishizawa Y; Tabata S; Ikeda R; Kawahara K; Tsujikawa K; Chijiiwa K; Yamada K; Akiyama S; Pérez-Torras S; Pastor-Anglada M; Furukawa T; Yasuo T
    J Pharmacol Sci; 2015 Mar; 127(3):319-25. PubMed ID: 25837929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of inactivation of human ribonucleotide reductase with p53R2 by gemcitabine 5'-diphosphate.
    Wang J; Lohman GJ; Stubbe J
    Biochemistry; 2009 Dec; 48(49):11612-21. PubMed ID: 19899807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cells.
    Myette MS; Elford HL; Chitambar CR
    Cancer Lett; 1998 Jul; 129(2):199-204. PubMed ID: 9719462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Iminodiacetate-Thiosemicarbazone Hybrids and Their Copper(II) Complexes Are Potential Ribonucleotide Reductase R2 Inhibitors with High Antiproliferative Activity.
    Zaltariov MF; Hammerstad M; Arabshahi HJ; Jovanović K; Richter KW; Cazacu M; Shova S; Balan M; Andersen NH; Radulović S; Reynisson J; Andersson KK; Arion VB
    Inorg Chem; 2017 Mar; 56(6):3532-3549. PubMed ID: 28252952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant.
    Bergman AM; Eijk PP; Ruiz van Haperen VW; Smid K; Veerman G; Hubeek I; van den Ijssel P; Ylstra B; Peters GJ
    Cancer Res; 2005 Oct; 65(20):9510-6. PubMed ID: 16230416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of chlamydial class Ic ribonucleotide reductase by C-terminal peptides from protein R2.
    Ohrström M; Popović-Bijelić A; Luo J; Stenmark P; Högbom M; Gräslund A
    J Pept Sci; 2011 Nov; 17(11):756-62. PubMed ID: 21976435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The identification of novel 5'-amino gemcitabine analogs as potent RRM1 inhibitors.
    Labroli MA; Dwyer MP; Shen R; Popovici-Muller J; Pu Q; Wyss D; McCoy M; Barrett D; Davis N; Seghezzi W; Shanahan F; Taricani L; Beaumont M; Malinao MC; Parry D; Guzi TJ
    Bioorg Med Chem; 2014 Apr; 22(7):2303-10. PubMed ID: 24588962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.